
CareLog is revolutionizing cardiovascular diagnostics with its breakthrough ECG AI model. The company offers a suite of AI-powered algorithms designed to detect silent cardiac indications, addressing the rising burden of heart diseases. With a focus on early diagnostics, CareLog aims to initiate preventive therapies efficiently. Their algorithms have been developed using ECG signals from over 100,000 patients and are undergoing rigorous testing in real-world environments. The company has already deployed its solutions at multiple locations and is collaborating with ECG manufacturers to expand its reach. CareLog's innovative approach positions it as a leader in the healthcare technology space, particularly in cardiology.

CareLog is revolutionizing cardiovascular diagnostics with its breakthrough ECG AI model. The company offers a suite of AI-powered algorithms designed to detect silent cardiac indications, addressing the rising burden of heart diseases. With a focus on early diagnostics, CareLog aims to initiate preventive therapies efficiently. Their algorithms have been developed using ECG signals from over 100,000 patients and are undergoing rigorous testing in real-world environments. The company has already deployed its solutions at multiple locations and is collaborating with ECG manufacturers to expand its reach. CareLog's innovative approach positions it as a leader in the healthcare technology space, particularly in cardiology.
What they do: AI algorithms that analyze ECGs to detect cardiac conditions (Diastolytix targets diastolic dysfunction/HFpEF)
Founded: 2023 (California, United States)
Funding: Pre-Seed $145,000 (reported Jun 4, 2024); lead investor Forum Ventures
Founders / leadership: Aman Alok (Founder & CEO), Sathis Kumar (Co‑founder / CTO)
Cardiovascular diagnostics; early detection of heart disease from ECG data.
2023
Data and Analytics
$145,000
Right Side Capital Management listed as participating investor